Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02606123
Title Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer
Recruitment Terminated
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors ESSA Pharmaceuticals
Indications

prostate adenocarcinoma

Therapies

EPI-506

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.